Please be aware that Mahajan Imaging & Labs will never request for your bank details or OTP for booking/registration purposes.

What is a MGMT-MS by PCR?

The **MGMT-MS by PCR test** is a molecular diagnostic test used to assess the methylation status of the *O6-methylguanine-DNA methyltransferase (MGMT)* gene promoter. MGMT is a DNA repair enzyme, and its promoter methylation can silence gene activity. This test is particularly important in brain tumors such as glioblastoma, as methylation status predicts response to alkylating chemotherapy agents like temozolomide. By identifying whether the MGMT gene is methylated, clinicians can personalize treatment strategies and improve patient outcomes.

Additional Information

Also known as/ Other names: MGMT Methylation Specific PCR, MGMT Promoter Methylation Test, MGMT Gene Methylation Analysis, MGMT Methylation Assay by PCR
Parameters: 1
Recommended for: M/F/Others
Sample Type: FFPE Tissue block
Patient Preparation: No prior preparation is needed
Reports: 12 Days

FAQs

How is the test conducted?

A tumor tissue sample is analyzed using PCR-based methylation-specific techniques to determine MGMT promoter methylation status.

What does a positive methylation result mean?

Positive methylation indicates silencing of the MGMT gene, often associated with better response to chemotherapy.

What does a negative methylation result mean?

Negative methylation suggests active MGMT gene, which may reduce chemotherapy effectiveness due to enhanced DNA repair.

Who should undergo this test?

Patients diagnosed with glioblastoma or other brain tumors are candidates for this test.

Can this test predict chemotherapy response?

Yes, methylation status helps predict how well patients will respond to alkylating agents like temozolomide.

Can this test monitor treatment effectiveness?

No, it is diagnostic. Clinical monitoring and imaging track treatment response.

Recommend more for you

Book Your Test
Text copied to clipboard
Dynamic badges will be added here